We are thrilled to announce ANTHELOS will participate in the partnering event be presenting at the upcoming BIO 2025 International Convention in Boston, USA on June 16-20, 2025.

At the event, ANTHELOS showcases its preclinical cellular platform to usher in a new generation of technologies for drug discovery in the field of lipid nanoparticles (LNP). This technology was partly developed from grant support grants from the National Research, Development, and Innovation Office (NKFI), Hungary – 2024-1.1.1-KKV_FÓKUSZ-2024-00062; „Development of multi-component lipid nanoparticles and microfluidic systems for the creation of new types of vaccines, gene therapy reagents and active substances, development of cellular and animal test systems”.

At the conference, ANTHELOS will share its cellular and in vivo screening solutions and platform technology for functional testing of potential LNP drugs and vaccines. If you’re attending the conference, we would like to connect with you and have discussions on how we can partner in developing breakthrough technologies for the preclinical LNP screening and testing. Our meetings will be scheduled in the Business Forum during the event.